A PHASE-II STUDY OF PIRITREXIM IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

被引：7
|
作者：
DEGARDIN, M
DOMENGE, C
CAPPELAERE, P
LUBOINSKI, B
NAVARRETE, MS
SCOTT, JE
LEFEBVRE, JL
机构：
[1] INST GUSTAVE ROUSSY,F-94805 VILLEJUIF,FRANCE
[2] SERV RECH CLIN,LAB WELLCOME,F-92442 ISSY MOULINEAUX,FRANCE
[3] WELLCOME RES LABS,BECKENHAM BR3 3BS,KENT,ENGLAND
来源：
EUROPEAN JOURNAL OF CANCER | 1994年 / 30A卷 / 07期
关键词：
D O I：
10.1016/0959-8049(94)90156-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1044 / 1045
页数：2
相关论文
共 50 条
  • [41] PHASE-II TRIAL OF CISPLATIN AND TEGAFUR (FTORAFUR) AS INITIAL THERAPY IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    GONZALEZBARON, M
    VICENTE, J
    TOMAS, M
    MARTIN, G
    MARTORELL, V
    GARCIAGIRON, C
    GARRIDO, P
    GAVILAN, J
    ZAMORA, P
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (04): : 312 - 314
  • [42] PHASE-II TRIAL OF RAZOXANE (ICRF-159) IN PREVIOUSLY TREATED PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA
    SHAH, MK
    CATALANO, RB
    ENGSTROM, PF
    BELLET, RE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 366 - 366
  • [43] EVALUATION OF HOMOHARRINGTONINE EFFICACY IN THE TREATMENT OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-II ILLINOIS CANCER COUNCIL STUDY
    RUNGEMORRIS, MA
    KIES, MS
    VOKES, E
    BLOUGH, R
    WEIDNER, L
    KNOP, R
    ROWLAND, K
    INVESTIGATIONAL NEW DRUGS, 1989, 7 (2-3) : 269 - 273
  • [44] PHASE-II EVALUATION OF MITOLACTOL IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A SOUTHEASTERN-CANCER-STUDY-GROUP TRIAL
    MCHALE, MS
    VELEZGARCIA, E
    NELSON, O
    WILLIAMS, SD
    MADDOX, W
    BIRCH, R
    CANCER TREATMENT REPORTS, 1986, 70 (07): : 925 - 926
  • [45] PHASE-II STUDY OF CARBOPLATIN AND EDATREXATE (10-EDAM) WITH LEUCOVORIN RESCUE FOR PATIENTS WITH RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    HUBER, MH
    DIMERY, IW
    BENNER, SE
    LIPPMAN, SM
    SHIRINIAN, M
    ESPARAZ, B
    FRENNING, D
    GUILLORYPEREZ, C
    HONG, WK
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (04) : 327 - 331
  • [46] A phase II study of ARQ 501 in patients with advanced squamous cell carcinoma of the head and neck
    Kawecki, A.
    Adkins, D. R.
    Cunningham, C. C.
    Vokes, E.
    Yagovane, D. M.
    Dombal, G.
    Koralewski, P.
    Hotko, Y.
    Vladimirov, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] BLEOMYCIN IN ADVANCED SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK
    GREY, P
    MICHAELS, L
    MEDICAL JOURNAL OF AUSTRALIA, 1972, 2 (05) : 246 - &
  • [48] Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck
    Specht, L
    Larsen, SK
    Hansen, HS
    ANNALS OF ONCOLOGY, 2000, 11 (07) : 845 - 849
  • [49] CHEMOTHERAPY IN ADVANCED HEAD AND NECK SQUAMOUS-CELL CARCINOMA
    LEHNERT, M
    JAKSE, R
    SEEWANN, HL
    ONKOLOGIE, 1984, 7 (05): : 297 - 299
  • [50] DACARBAZINE IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    BUESA, JM
    FERNANDEZ, R
    BARON, FJ
    PALACIO, I
    CUEVA, J
    ESTEBAN, E
    GRACIA, JM
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (02) : 215 - 216
12345